Kidney Stone Management Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Kidney Stone Management Market will expand at a CAGR of 5.1% during 2024-2032, driven by the rising prevalence of kidney stones globally. Factors such as dietary changes, increasing obesity rates, and sedentary lifestyles lead to the condition. For instance, a study published in the Journal of Urology (2022) noted a 10% rise in kidney stone cases over the past decade. The aging population, more prone to kidney stones, further boosts the demand for advanced diagnostic and treatment options. Advances in medical technology, including minimally invasive surgical techniques and improved imaging modalities, enhance treatment effectiveness and patient outcomes.
Increased awareness about kidney stone prevention and management among healthcare professionals and the public fuels market growth. Government initiatives and healthcare campaigns, such as the National Kidney Foundation's awareness programs, educate individuals about preventive measures and early detection, driving demand for management solutions. Innovative therapies, including new medications and novel surgical approaches, supported by ongoing research and clinical trials, are expected to further propel market growth.
The kidney stone management industry is classified based on type, diagnostics, treatment, end-user, and region.
The ultrasound segment is experiencing significant growth due to its non-invasive nature, real-time imaging capabilities, and lack of ionizing radiation. Ultrasound technology allows for effective detection and assessment of kidney stones, providing detailed visualization of stone size, location, and potential complications. Its portability and ease of use in various clinical settings enhance its appeal, contributing to its widespread adoption. Furthermore, advancements in ultrasound technology, such as the integration of high-definition imaging and improved sensitivity, are enhancing diagnostic accuracy and patient outcomes.
The ureteroscopy segment will account for a notable market share by 2032, due to its efficacy in treating stones located in the ureters and kidneys with minimal invasiveness. Ureteroscopy offers several advantages, including reduced recovery times, less post-operative pain, and lower risk of complications compared to traditional surgical methods. Technological innovations, such as the development of ultra-thin ureteroscopes and advanced laser systems, have significantly improved the precision and success rates of this procedure.
Europe kidney stone management market will witness substantial growth through 2032, driven by an increasing prevalence of kidney stones, an aging population, and rising awareness about advanced treatment options. Europe benefits from a well-established healthcare infrastructure, which supports the widespread adoption of innovative diagnostic and therapeutic technologies. Additionally, favorable government policies and healthcare initiatives aimed at improving patient outcomes and promoting preventive care are further propelling market expansion. The presence of key players and ongoing research into new treatment modalities contribute to a regional market growth.
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence and recurrence rate of kidney stones globally
3.2.1.2 Advancements in ureteroscopy technique
3.2.1.3 Favourable reimbursement for lithotripsy procedures
3.2.1.4 Inclination towards undergoing minimally invasive surgeries
3.2.1.5 Rising awareness regarding overall kidney health
3.2.2 Industry pitfalls and challenges
3.2.2.1 Lack of treatment awareness in certain countries
3.2.2.2 Potential long-term adverse effects of lithotripsy
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
3.7 Reimbursement scenario
3.8 Gap analysis
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Calcium oxalate
5.3 Calcium phosphate
5.4 Uric acid
5.5 Struvite
5.6 Cysteine
Chapter 6 Market Estimates and Forecast, By Diagnostics, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Abdominal x-ray
6.3 Computed tomography
6.4 Ultrasound
6.5 Abdominal MRI
6.6 Intravenous pyelography
6.7 Other diagnostics
Chapter 7 Market Estimates and Forecast, By Treatment, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Abdominal x-ray
7.3 Extracorporeal shock wave lithotripsy (ESWL)
7.4 Ureteroscopy
7.5 Percutaneous nephrolithotomy (PCNL)
7.6 Other treatments
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Specialty clinics
8.4 Ambulatory surgical centers
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)